Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CMS finalizes policies to reduce drug costs for Medicare beneficiaries

Published 04/03/2018, 09:42 AM
Updated 04/03/2018, 09:42 AM
© Reuters.  CMS finalizes policies to reduce drug costs for Medicare beneficiaries
  • The U.S. Health and Human Services' Centers for Medicare & Medicaid Services (CMS) has finalized a number of new policies aimed at lowering drug costs for seniors by encouraging more competition among plans and pharmacies. Specifically:
  • Certain generic drugs can now be substituted onto plan formularies at any point during the year.
  • The requirement that certain Part D plans be "meaningfully different" from each other removed thereby increasing the number of plan options available to Medicare beneficiaries.
  • "Willing provider" requirement clarified thereby increasing the number of pharmacy options available to Medicare enrollees.
  • Other policies being instituted:
  • New authority that permits Part D sponsors to require beneficiaries at risk of opioid addiction/overuse to use only selected prescribers or pharmacies for opioid prescriptions.
  • New initiatives aimed at reducing paperwork and regulatory obstacles.
  • Selected tickers: XLV IHE XPH PPH GNRX XBI BIB OTCQX:RHHBY ABBV AGN AZN BMY GSK JNJ LLY MRK NVO NVS PFE SHPG VRX TEVA MYL PRGO CVS WBA UNH AET CI AMED KND LHCG
  • Now read: This Dividend Aristocrat Just Printed 20%+ EPS Growth - Is It A Buy?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.